This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignee: Arisgen Sa. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: Sylvie Tchertchian: Innovator in Mucosal Drug Delivery
Introduction
Sylvie Tchertchian is a prominent inventor based in Monnetier-Mornex, France. She has made significant contributions to the field of drug delivery, particularly through her innovative approaches to mucosal delivery systems. With a total of 3 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Tchertchian's latest patents focus on mucosal delivery of drugs. One of her notable inventions provides a composition that includes at least one mono-alkanoyl glycerol ester and a compound selected from cholesterol, phosphatidyl cholines, and phosphatidyl glycerols. This invention aims to enhance the effectiveness of drug delivery through mucosal routes. Another patent involves mucosal delivery compositions that include a peptide complexed with a crown compound and/or a counter ion. These compositions are designed for the stable hydration of peptide active agents, which can be administered effectively to treat various disease conditions.
Career Highlights
Sylvie Tchertchian is currently associated with Arisgen SA, where she continues to develop her innovative ideas in drug delivery systems. Her work is characterized by a strong focus on improving the efficacy of treatments through advanced delivery methods.
Collaborations
Tchertchian collaborates with notable colleagues, including Paolo Botti and Doriane Theurillat. These partnerships enhance her research and development efforts, contributing to the success of her projects.
Conclusion
Sylvie Tchertchian's contributions to mucosal drug delivery represent a significant advancement in the field of pharmaceuticals. Her innovative patents and collaborative efforts are set to impact the treatment of various medical conditions positively.